Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Food, Supplement Health Claim Oversight Shift Urged In House Bill

This article was originally published in The Tan Sheet

Executive Summary

FDA's authority to approve health claims for foods and dietary supplements would be removed under a bill introduced in the House Feb. 27 by Rep. Ron Paul (R-Texas)

You may also be interested in...



Health claims bill

"Health Information Independence Act" introduced in the House March 18 by Rep. Ron Paul (R-Tex.) would amend the FD&C Act by moving oversight of health claims from FDA to an independent review board. Legislation is similar to a 2002 bill sponsored by Paul (1"The Tan Sheet" March 4, 2002, p. 4)...

Health claims bill

"Health Information Independence Act" introduced in the House March 18 by Rep. Ron Paul (R-Tex.) would amend the FD&C Act by moving oversight of health claims from FDA to an independent review board. Legislation is similar to a 2002 bill sponsored by Paul (1"The Tan Sheet" March 4, 2002, p. 4)...

Health claims bill

"Health Information Independence Act" introduced in the House March 18 by Rep. Ron Paul (R-Tex.) would amend the FD&C Act by moving oversight of health claims from FDA to an independent review board. Legislation is similar to a 2002 bill sponsored by Paul (1"The Tan Sheet" March 4, 2002, p. 4)...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel